Bionomics Long Term Debt 2022-2024 | NEUP
Bionomics long term debt from 2022 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Bionomics Annual Long Term Debt
(Millions of US $) |
| 2024 |
$ |
| 2023 |
$ |
| 2022 |
$0 |
| 2021 |
$1 |
Bionomics Quarterly Long Term Debt
(Millions of US $) |
| 2024-09-30 |
|
| 2024-06-30 |
|
| 2023-09-30 |
|
| 2023-06-30 |
$0 |
| 2022-12-31 |
$0 |
| 2022-06-30 |
$0 |
| 2021-06-30 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
